GLGuangxin Li

Guangxin Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Guangxin Li has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering

    by Jiesi Luo, Yuyao Lin, Xiangyu Shi, Guangxin Li, Mehmet H. Kural, Christopher W. Anderson, Matthew W. Ellis, Muhammad Riaz, George Tellides, Laura E. Niklason, et al.


  • Open Access

    Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib

    by Zhengxing Gao, Chunqing Song, Guangxin Li, Haishan Lin, Xiangyao Lian, Ninggang Zhang, Bangwei Cao

    Aims: Pyrotinib is a newly developed irreversible pan-ErbB receptor tyrosine kinase inhibitor for treatment of human epidermal growth factor receptor 2 (HER2)-positive cancers, and clinic trials of pyrotinib in treatment of HER2-positive gastric cancer (GC) are underway. Exosomes are tiny vesicles secreted by cancer cells and take essential roles in the progression of carcinoma. Whether pyrotinib application has any effect on the cancer cell-released exosomes has not been studied. The aim of our work was to address if pyrotinib treatment impacts the effect of HER2-positive GC cell-derived exosomes on endothelial cell (EC) progression. Methods: Isolation of exosomes released by HER2-positive NCI-N87 and MKN45 lines after pyrotinib treatment was performed. Then, human umbilical vein endothelial cells (HUVECs) were incubated with different concentrations of exosomes to address their proliferation by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS). Effect of pyrotinib-treated exosomes at concentration of 10 μg/mL was compared to that without pyrotinib treatment over 96-hr time course. Transwell assay and wound-healing assay were carried out by incubating with exosomes released by NCI-N87 and MKN45 cells with/without pyrotinib treatment over 24-hr time course. The aforementioned experiments were done under same conditions in order to evaluate the combined effect of apatinib and pyrotinib on HUVEC motility and invasive capacity. Results: We showed that HUVEC proliferation, motility and invasive capacity were further enhanced upon incubation with exosomes released by pyrotinib-treated GC cell lines, compared to those without pyrotinib treatment. Significantly, this effect was counteracted by the vascular endothelial growth factor receptor (VEGFR)-2 inhibitor apatinib which inhibits EC progression. Conclusion: Our study suggests that pyrotinib application on HER2-positive GC produces stronger exosomes that promote the proliferation and motility of vascular ECs, and combination of pyrotinib with apatinib provides potentially better therapy.


  • Effect of surface shallow traps on flashover characteristics across machinable ceramic in vacuum

    by Kai-Kun Yu, Guan-Jun Zhang, Guo-Qing Liu, Xin-Pei Ma, Guang-Xin Li

    The electrical strength of the surface of low-temperature melting machinable glass ceramic, prepared by using several different methods, is investigated before and after treatment with diluted hydrofluoric acid (HF). Using the surface potential decay method, the surface trap density and the energy of each sample are measured. The influence of acid treatment on the trap distribution is analyzed. Concurrent optical and electrical measurements allow surface flashover phenomena in vacuum under impulse voltage to be investigated, along with the influence of surface trapping parameters on flashover performance. It is shown that the glass phase on the surface of machinable ceramic greatly influences the shallow traps, which in turn degrade the flashover characteristics. Removing the glass phase with HF treatment reduces the concentration of shallow traps and stabilizes the flashover voltage.